Feature | VIVA | November 14, 2019

VIVA 2019 Late-breaking Clinical Trials

The latest clinical data in vascular medicine and peripheral vascular interventions

Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at Vascular Interventional Advances (VIVA) 2019 conference. These results were presented in four different sessions on Nov. 5-6, 2019, in VIVA's Global Theater. VIVA highlights the latest science in vascular and peripheral vascular interventions.
 

Tuesday Late-breakers, November 5:

   • No Increased Mortality for the Zilver PTX Drug-Eluting Stent Compared to Uncoated Devices, presented by Michael Dake, M.D.

   • A Novel Sustained Sirolimus Release Eluting Balloon: 2-Year Data From the SELUTION SFA Trial, presented by Thomas Zeller, M.D., Ph.D.

   • RANGER II SFA: Randomized Trial of RANGER DCB vs. PTA in the SFA, presented by Ravish Sachar, M.D.

   • 4-Year Outcomes From the IN.PACT Global Study, presented by Thomas Zeller, M.D., Ph.D.

   • DCB vs POBA After B-laser Atherectomy Shows No Difference, presented by John Rundback, M.D.

   • Two-Year Outcomes From the IMPERIAL Randomized Trial of Eluvia and Zilver PTX, presented by Osamu Iida, M.D.

 

   • Full Cohort 24-Month Safety and Efficacy Results of the VMI-CFA Common Femoral Stenting Trial, presented by Koen Deloose, M.D.

   • Nexus Aortic Arch Branch Stent-Graft System – Mid-Term Results, presented by Mario Lachat, M.D.

   • Revolution Rotational Atherectomy System IDE Experience, presented by Jeffrey Carr, M.D.

   • 1-year Results From the MIMICS-3D Registry: Investigating the BioMimics 3D Stent, presented by Michael Lichtenberg, M.D.

   • Treatment of BTK Disease With a Novel Device: Update on the DEEPER OUS Trial, presented by Thomas Zeller, M.D., Ph.D.

 

Wednesday Late-breakers, November 6:

   • 6-Months Results of TOBA II BTK, presented by George Adams, M.D.

   • 5-Year ABSORB BTK Trial Results, presented by Ramon Varcoe, MBBS, MS, Ph.D.

   • Results of the PROMISE I Trial Using the LimbFlow Bypass System in Limb-threatening Ischemia, presented by Daniel Clair, M.D.

   • Initial 12-Month Outcomes From the TANGO Trial (Adventitial Temsirolimus in BTK Lesions), presented by Ehrin Armstrong, M.D.

   • The Ulysse Registry Shows Benefit of Ultrasoundplasty in Below-the-knee Interventions, presented by Costantino Del Giudice, M.D., Ph.D.

    
   • IN.PACT AV Access 6-month Lesion Outcomes, presented by Robert Lookstein, M.D., MHCDL

   • Lateral Subdermic Plexus Insufficiency: A Paradigm Shift With Restless Leg Syndrome, presented by Swar Shah, M.D.

   • Early Outcomes From the ClotTriever (CLOUT) Registry in DVT, presented by David Dexter, M.D.

   • Indigo Aspiration System for Acute Pulmonary Embolism, presented by Akhilesh Sista, M.D.

   • 1-Year Results of the DISAPEAR Registry, presented by Steven Kum, M.D.

 

 
Related Late-breaking Cardiovascular Trials:

ACC 2019 Late-breaking Presentations

Late-breaking Interventional Cardiology Presentations at SCAI 2019

American Heart Association 2018 Late-breaking Trials

TCT 2019 Late-breaking Presentations

American Heart Association 2019 Late-breaking Trials

Related Content

News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
News | Cath Lab

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

Home November 10, 2021
Home
Subscribe Now